Potential Modes of Intercellular α-Synuclein Transmission

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Intracellular aggregates of alpha-synuclein protein are hallmarks of Parkinson's disease and related synucleinopathies.
• These aggregates lead to neuronal cell loss and dysfunction, contributing to disease progression.
• The precise mechanisms of alpha-synuclein-mediated cytotoxicity and its cell-to-cell propagation are not fully understood.

Purpose of the Study:

• To review the current evidence on the different modes of alpha-synuclein cellular release, movement, and uptake.
• To highlight the significance of cell-to-cell spread in the propagation of alpha-synuclein pathology.
• To identify potential therapeutic targets by understanding disease spread mechanisms.

Main Methods:

• Literature review of studies investigating alpha-synuclein pathology.
• Analysis of evidence for various cellular release and uptake mechanisms.
• Synthesis of findings related to cell-to-cell transmission of alpha-synuclein.

Main Results:

• Alpha-synuclein pathology is implicated in Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.
• Cell-to-cell spread of alpha-synuclein is identified as a major driver of disease progression.
• Multiple pathways, including exocytosis, exosomes, tunneling nanotubes, glymphatic flow, and endocytosis, are involved in alpha-synuclein propagation.

Conclusions:

• Understanding the diverse mechanisms of alpha-synuclein spread is crucial for developing effective treatments.
• Targeting the cell-to-cell transmission of alpha-synuclein may offer a novel therapeutic strategy for synucleinopathies.
• Further research into these pathways can illuminate new avenues for halting neurodegenerative disease progression.